Avenue Therapeutics Earning Date (ATXI)

USA |NASDAQ |USD

ATXI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 16, 2022 (est) Jun 30, 2022 - $-0.14 $-0.06
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 16, 2022 (est) Jun 30, 2022 - $0.00 $0.00

Avenue Therapeutics's next estimated earnings date (based on same quarter last year's date) is Aug 16, 2022 for the fiscal quarter ending Jun 30, 2022.

ATXI Earnings Date & History Chart

ATXI Earnings & Revenue Forecast

ATXI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 0 $0.00 $0.00 $0.00

ATXI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.19 $-0.19 $-0.19

ATXI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.00 $0.00 $0.00

ATXI Earnings Date & Revenue History

ATXI Earnings History

|
Show More
Show More

ATXI Revenue History

|
Show More
Show More

Avenue Therapeutics Next Earnings Date & Report

ATXI May 2022 (FQ) Earnings Date & Report Preview

ATXI's next estimated earnings date (based on same quarter last year's report date) is Aug 16, 2022 for the fiscal quarter ending Jun 30, 2022.

Avenue Therapeutics Previous Earnings Dates & Reports

ATXI Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Avenue Therapeutics's previous earnings date was May 27, 2022 for its fiscal quarter ended Mar 31, 2022.

ATXI's earnings per share (EPS) was $-0.14.

The EPS was lower than the previous fiscal quarter (Dec 2021) by 175.76%, and lower than the same period a year before (Mar 2021) by 127.50%.

Revenues were $0.00.

The company reported a net income of $-2.86M.

Free cash flow for the quarter was $-1.93M , compared to $2.54M last quarter and $-1.31M a year before.

ATXI Previous Earnings Date & Report Recap: Dec 2021 (FY)

Avenue Therapeutics's previous annual earnings date was Mar 25, 2022 for its fiscal year ended Dec 31, 2021.

ATXI's earnings per share (EPS) was $-0.22, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Dec 2020) by -29.19%.

Revenues were $0.00.

The company reported a net income of $-3.73M.

Avenue Therapeutics reported a free cash flow of $-3.75K for its fiscal year, compared to $-4.61K a year ago.